Ranitidine (McKesson Packaging Services Business Unit of McKesson Corporation)


Welcome to the PulseAid listing for the Ranitidine drug offered from McKesson Packaging Services Business Unit of McKesson Corporation. This Histamine H2 Receptor Antagonists [MoA],Histamine-2 Receptor Antagonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: McKesson Packaging Services Business Unit of McKesson Corporation
NON-PROPRIETARY NAME: Ranitidine
SUBSTANCE NAME: RANITIDINE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Histamine H2 Receptor Antagonists [MoA],Histamine-2 Receptor Antagonist [EPC]
ROUTE: ORAL
DOSAGE FORM: TABLET
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2004-07-01
END MARKETING DATE: 0000-00-00


Ranitidine HUMAN PRESCRIPTION DRUG Details:

Item DescriptionRanitidine from McKesson Packaging Services Business Unit of McKesson Corporation
LABELER NAME: McKesson Packaging Services Business Unit of McKesson Corporation
DEA SCHEDULE:
ACTIVE STRENGTH: 150(mg/1)
START MARKETING DATE: 2004-07-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 63739-266_7b5c59ae-e4c1-4097-9db1-f6837b7c3688
PRODUCT NDC: 63739-266
APPLICATION NUMBER: ANDA075180

Other RANITIDINE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
ATLANTIC BIOLOGICALS CORP.Ranitidine
McKesson Packaging Services Business Unit of McKesson CorporationRanitidine
Pharmaceutical Associates, Inc.Ranitidine
Sandoz Inc.Ranitidine
State of Florida DOH Central PharmacyRanitidine